April 28, 2022
1 min watch
Stanford reviews serving as a medical adviser for Boehringer Ingelheim, Calibrate, Coral Health, Eli Lilly & Co., Gelesis, GoodRX, Novo Nordisk and Pfizer.
In this video, Healio Primary Care Peer Perspective Board Member Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, discusses her displays on weight problems from the ACP Internal Medicine Meeting.
Stanford is an weight problems medication doctor and director of fairness for the endocrine division at Massachusetts General Hospital.
In one presentation, she’s going to talk about the suitable use of GLP1-agonists in sufferers with weight problems, together with those that underwent bariatric surgical procedure. Most anti-obesity pharmacotherapies might be labeled into three major teams, in line with Stanford: centrally performing medicines that impair dietary consumption; medicines that act peripherally to impair dietary absorption; and medicines that improve vitality expenditure. As 25% to 35% of bariatric surgical procedure sufferers have important weight acquire inside 2 to five years after their surgical procedure, pharmacotherapy could also be an efficient adjunct.
In the second presentation, Stanford and colleagues will talk about the affect of consuming habits on world well being. The proportion of adults with obese or weight problems has continued to rise over the last 2 many years.
“This might be a broad presentation actually taking a look at all the problems we’re seeing nation to nation because it pertains to points like obese and weight problems but additionally malnutrition and meals insecurity,” Stanford mentioned.
Brook R, et al. MSFM: Neurology, psychiatry, and metabolism. Presented at: ACP Internal Medicine Meeting; April 28-30, 2022; Chicago.
Duffy W, et al. Food as a medical intervention. Presented at: ACP Internal Medicine Meeting; April 28-30, 2022; Chicago.